Literature DB >> 3728971

A highly sensitive assay method for human placental alkaline phosphatase involving a monoclonal antibody bound to a paper disk.

K Hirano, Y Iiizumi, Y Hayashi, T Tanaka, M Sugiura, K Hayashi, Z D Lu, S Iino.   

Abstract

A monoclonal antibody which is specific for human placental alkaline phosphatase and does not cross-react at all with intestinal alkaline phosphatase was prepared, and a procedure for the determination of placental alkaline phosphatase activity in serum was developed involving this monoclonal antibody bound to a paper disk. The minimum amount of placental alkaline phosphatase detectable by this method is 0.0025 King-Armstrong unit. Good correlation with the heat-treatment method was obtained. Therefore this proposed method can be used as a routine clinical test for the determination of serum placental alkaline phosphatase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3728971     DOI: 10.1016/0003-2697(86)90038-2

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

1.  Purification and characterisation of the placental-like alkaline phosphatase from ovarian epithelial tumours.

Authors:  I Koyama; K Hirano; R Makiya; U Stendahl; T Stigbrand
Journal:  Br J Cancer Suppl       Date:  1990-07

2.  Murine antibody responses distinguish Rochalimaea henselae from Rochalimaea quintana.

Authors:  L N Slater; D W Coody; L K Woolridge; D F Welch
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

3.  Bacteremia due to Rochalimaea henselae in a child: practical identification of isolates in the clinical laboratory.

Authors:  D F Welch; D M Hensel; D A Pickett; V H San Joaquin; A Robinson; L N Slater
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

4.  Improved survival of mice bearing liver metastases of colon cancer cells treated with a combination of radioimmunotherapy and antiangiogenic therapy.

Authors:  Seigo Kinuya; Kunihiko Yokoyama; Kiyoshi Koshida; Hirofumi Mori; Kazuhiro Shiba; Naoto Watanabe; Noriyuki Shuke; Jingming Bai; Takatoshi Michigishi; Norihisa Tonami
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-28       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.